A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
2013 · British Journal of Cancer · 158 citations
https://doi.org/10.1038/bjc.2013.408
C
Chen‐Hao Yeh
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
1.5K
Citations
19
h-index
20
i10-index
Chen‐Hao Yeh is an academic researcher from Duke University. The author has contributed to research in topics: T-cell and B-cell Immunology & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 19, co-authored 24 publications.
ORCID: 0000-0001-5801-2918Papers by this author
worksA soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities
1997 · The Journal of Immunology · 77 citations
https://doi.org/10.4049/jimmunol.158.6.2872
Recall of B cell memory depends on relative locations of prime and boost immunization
2022 · Science Immunology · 57 citations
https://doi.org/10.1126/sciimmunol.abn5311
Immune checkpoint modulation enhances HIV-1 antibody induction
2020 · Nature Communications · 36 citations
https://doi.org/10.1038/s41467-020-14670-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat